7 employees
Ethicann Pharmaceuticals uses pharmaceutical-grade botanically sourced cannabinoid oils to formulate ethical drugs.
2018
Ethicann Pharmaceuticals, Inc. raised undisclosed on June 29, 2022
Investors: Keiretsu Capital